FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2515729782> ?p ?o ?g. }

• W2515729782 endingPage "952" @default.
• W2515729782 startingPage "952" @default.
• W2515729782 abstract "Abstract Abstract 952 Acute myeloid leukemia (AML) is clinically, cytogenetically and molecularly a heterogeneous disease which makes it challenging to classify it properly. In recent years major advances have been achieved in predicting outcome. However, there is still need for more powerful and independent prognostic factors that can guide treatment decisions, especially for the large subgroup of patients presenting with normal karyotype AML. In order to improve the identification of prognostic markers, gene expression studies have been performed. However, most of these studies have analyzed the mononuclear cell fraction. So, very little has been revealed about gene expression programs that drive leukemic transformation in the small population of leukemic stem cells (LSCs). Although considerable heterogeneity appears to exist in the phenotype of LSCs, CD34 is uniformly expressed and LSCs have been found to reside in the CD34+ compartment in the vast majority of leukemias. In the present study AML CD34+-specific gene expression profiles were indentified and used to distinguish prognostically relevant target genes in normal karyotype AML. AML mononuclear cells (n=46) were sorted in CD34+ and CD34- subfractions and genome-wide expression analysis was performed using Illumina BeadChip Arrays. AML CD34+ and CD34- gene expression was compared to a large group of normal CD34+ bone marrow cells (n=31). Unsupervised hierarchical clustering analysis showed that CD34+ AML samples belonged to a distinct cluster compared to normal bone marrow and that in 61% of the cases the AML CD34+ transcriptome did not cluster together with the paired CD34- transcriptome. These data indicate that in the majority of AML cases the leukemic stem cell-enriched CD34+ gene expression profile is quite distinct from the leukemic CD34- compartment. GO analysis revealed that common differences in gene expression between CD34+ and CD34- groups were particularly enriched for genes that were associated with T-cells and erythropoiesis. This association with a more committed phenotype was found in all AML samples and not just in those samples where CD34+ and CD34- transcriptomes did not cluster together. Among the GO-ontologies representing the differentially expressed genes between CD34+ AML versus CD34+ normal bone marrow cells were gene sets related to DNA damage and a number of mitotic and metabolic processes. A top 50 of AML CD34+-specific genes was selected by comparing the AML CD34+ transcriptome with the AML CD34- and CD34+ normal bone marrow transcriptomes. The prognostic relevance of these 50 genes was assessed using univariate cox regression analyses between the continuous transcript levels of these 50 genes and overall survival (OS) in a large series of normal karyotype AML (n=163) (Metzeler et al. Blood 2008). The findings were validated in another independent cohort of 218 normal karyotype AML patients (Valk et al. NEJM 2004). Interestingly, higher transcript levels of three CD34+ AML specific genes, i.e. ankyrin repeat domain 28 (ANKRD28), guanine nucleotide binding protein, alpha 15 (GNA15) and UDP-glucose pyrophosphorylase 2 (UGP2) were associated with a significant poorer OS in both cohorts (p<0.01). For the cohort of 218 normal karyotype AML patients also event free survival (EFS) data were available for further analyses. A significant association between the continuous transcript levels of ANKRD28, GNA15 and UGP2 with poor EFS was evident. Also for the sum of expression of ANKRD28, GNA15 and UGP2 higher transcript levels were strongly associated with poorer OS (p=0.007) and EFS (p=0.006) in the cohort of 218 normal karyotype AML. Similar results were obtained in the cohort of 163 normal karyotype AML patients for OS (p<0.001). Importantly, the prognostic value of the continuous transcript levels of these three genes was independent from the well known risk factors FLT3-ITD, NPM1c+ and CEBPA mutation status as determined by a multivariate analysis in the cohort of 218 normal karyotype AML patients. In conclusion, by microarray analysis of the leukemic stem cell-enriched AML CD34+ cell fraction novel insight was obtained in gene expression programs that are potentially associated with leukemic stem cell self-renewal and transformation. Moreover, the identified new gene expression profiles were shown to have prognostic relevance in normal karyotype AML independent of well known risk factors. Disclosures: No relevant conflicts of interest to declare." @default.
• W2515729782 created "2016-09-16" @default.
• W2515729782 creator A5010075077 @default.
• W2515729782 creator A5011506752 @default.
• W2515729782 creator A5015369860 @default.
• W2515729782 creator A5019504095 @default.
• W2515729782 creator A5023998748 @default.
• W2515729782 creator A5026402394 @default.
• W2515729782 creator A5035002547 @default.
• W2515729782 creator A5050532707 @default.
• W2515729782 creator A5052818599 @default.
• W2515729782 creator A5059620488 @default.
• W2515729782 creator A5059851212 @default.
• W2515729782 date "2010-11-19" @default.
• W2515729782 modified "2023-09-30" @default.
• W2515729782 title "Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34+ Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML" @default.
• W2515729782 doi "https://doi.org/10.1182/blood.v116.21.952.952" @default.
• W2515729782 hasPublicationYear "2010" @default.
• W2515729782 type Work @default.
• W2515729782 sameAs 2515729782 @default.
• W2515729782 citedByCount "1" @default.
• W2515729782 countsByYear W25157297822021 @default.
• W2515729782 crossrefType "journal-article" @default.
• W2515729782 hasAuthorship W2515729782A5010075077 @default.
• W2515729782 hasAuthorship W2515729782A5011506752 @default.
• W2515729782 hasAuthorship W2515729782A5015369860 @default.
• W2515729782 hasAuthorship W2515729782A5019504095 @default.
• W2515729782 hasAuthorship W2515729782A5023998748 @default.
• W2515729782 hasAuthorship W2515729782A5026402394 @default.
• W2515729782 hasAuthorship W2515729782A5035002547 @default.
• W2515729782 hasAuthorship W2515729782A5050532707 @default.
• W2515729782 hasAuthorship W2515729782A5052818599 @default.
• W2515729782 hasAuthorship W2515729782A5059620488 @default.
• W2515729782 hasAuthorship W2515729782A5059851212 @default.
• W2515729782 hasConcept C10205521 @default.
• W2515729782 hasConcept C104317684 @default.
• W2515729782 hasConcept C150194340 @default.
• W2515729782 hasConcept C162317418 @default.
• W2515729782 hasConcept C18431079 @default.
• W2515729782 hasConcept C203014093 @default.
• W2515729782 hasConcept C2778461978 @default.
• W2515729782 hasConcept C2778729363 @default.
• W2515729782 hasConcept C2779282312 @default.
• W2515729782 hasConcept C2780007613 @default.
• W2515729782 hasConcept C28328180 @default.
• W2515729782 hasConcept C2908647359 @default.
• W2515729782 hasConcept C502942594 @default.
• W2515729782 hasConcept C54355233 @default.
• W2515729782 hasConcept C71924100 @default.
• W2515729782 hasConcept C86803240 @default.
• W2515729782 hasConcept C99454951 @default.
• W2515729782 hasConceptScore W2515729782C10205521 @default.
• W2515729782 hasConceptScore W2515729782C104317684 @default.
• W2515729782 hasConceptScore W2515729782C150194340 @default.
• W2515729782 hasConceptScore W2515729782C162317418 @default.
• W2515729782 hasConceptScore W2515729782C18431079 @default.
• W2515729782 hasConceptScore W2515729782C203014093 @default.
• W2515729782 hasConceptScore W2515729782C2778461978 @default.
• W2515729782 hasConceptScore W2515729782C2778729363 @default.
• W2515729782 hasConceptScore W2515729782C2779282312 @default.
• W2515729782 hasConceptScore W2515729782C2780007613 @default.
• W2515729782 hasConceptScore W2515729782C28328180 @default.
• W2515729782 hasConceptScore W2515729782C2908647359 @default.
• W2515729782 hasConceptScore W2515729782C502942594 @default.
• W2515729782 hasConceptScore W2515729782C54355233 @default.
• W2515729782 hasConceptScore W2515729782C71924100 @default.
• W2515729782 hasConceptScore W2515729782C86803240 @default.
• W2515729782 hasConceptScore W2515729782C99454951 @default.
• W2515729782 hasIssue "21" @default.
• W2515729782 hasLocation W25157297821 @default.
• W2515729782 hasOpenAccess W2515729782 @default.
• W2515729782 hasPrimaryLocation W25157297821 @default.
• W2515729782 hasRelatedWork W1516501920 @default.
• W2515729782 hasRelatedWork W2121159001 @default.
• W2515729782 hasRelatedWork W2141395967 @default.
• W2515729782 hasRelatedWork W2236712884 @default.
• W2515729782 hasRelatedWork W2360105106 @default.
• W2515729782 hasRelatedWork W2372009164 @default.
• W2515729782 hasRelatedWork W2387946178 @default.
• W2515729782 hasRelatedWork W2410107327 @default.
• W2515729782 hasRelatedWork W42711520 @default.
• W2515729782 hasRelatedWork W4303945795 @default.
• W2515729782 hasVolume "116" @default.
• W2515729782 isParatext "false" @default.
• W2515729782 isRetracted "false" @default.
• W2515729782 magId "2515729782" @default.
• W2515729782 workType "article" @default.